|
[1] LIU Y, CHEN GZ. Recommended diagnostic criteria for Castleman’s disease[J]. Chin J Pathol, 2013, 42 (9) :644-647. (in Chinese) 刘勇, 陈国璋. Castleman病的诊断标准建议[J].中华病理学杂志, 2013, 42 (9) :644-647.
|
|
[2] van RHEE F, WONG RS, MUNSHI N, et al. Sihuximab for multicentric Castleman’s disease:A randomised, doubleblind, placebo-controlled trial[J]. Lancet Oncol, 2014, 15 (9) :966-974.
|
|
[3] ZHANG L, LI J. Advances in studies on the pathogenesis of Castleman’s disease[J]. Acta Acad Med Sin, 2016, 38 (1) :118-121. (in Chinese) 张路, 李剑. Castleman病发病机制研究进展[J].中国医学科学院学报, 2016, 38 (1) :118-121.
|
|
[4] LIU WW, GE CL. Castleman’s disease[J]. Chin J Bases and Clin Gen Surg, 2010, 17 (8) :868-871. (in Chinese) 刘炜炜, 葛春林. Castleman病[J].中国普外基础与临床杂志, 2010, 17 (8) :868-871.
|
|
[5] DISPENZIERI A. Castleman disease[J]. Cancer Treat Res, 2008, 142:293-330.
|
|
[6] BUCHER P, CHASSOT G, ZUFFEREY G, et al. Surgical management of abdominal and retroperitoneal Castleman’s disease[J]. World J Surg Oncol, 2005, 3:33.
|
|
[7] FU YP. Castleman's disease of the colon in 1 case[J]. Chin J Clin Oncol, 2012, 39 (16) :1247. (in Chinese) 傅燕萍.结肠Castleman病1例[J].中国肿瘤临床, 2012, 39 (16) :1247.
|
|
[8] SHI CY, FENG Y, ZHANG L, et al. Case of mesorectal Casfleman disease[J]. Chin J Gen Surg, 2018, 33 (1) :29. (in Chinese) 施春雨, 冯野, 张磊, 等.直肠系膜Castleman病一例[J].中华普通外科杂志, 2018, 33 (1) :29.
|
|
[9] ARLET JB, HERMINE O, DARNIGE L, et al. Iron-deficiency anemia in Castleman disease:Implication of the interleukin 6/hepcidin pathway[J]. Pediatrics, 2010, 126 (6) :2010-1123.
|
|
[10] DONG J, XU WF, ZHOU JM, et al. Retroperitoneal Castleman’s disease:A report of 13 cases and literature review[J]. Chin J Min Inv Surg, 2018, 18 (9) :787-791. (in Chinese) 东洁, 徐维锋, 周敬敏, 等.腹膜后Castleman病13例报告并文献复习[J].中国微创外科杂志, 2018, 18 (9) :787-791.
|
|
[11] UYSAL B, DEMIRAL S, GAMSIZ H, et al. Castleman’s disease and radiotherapy:Asinglecenterexperience[J]. J Cancer Res Ther, 2015, 11 (1) :170-173.
|
DownLoad: